Bridge Laboratories has reached an agreement to build its second preclinical facility in China. This purpose-built, 150,000-sq.-ft. facility will be adjacent to the company’s existing laboratory in the Zhongguancun Life Science Park located in Beijing. Construction will begin in 4Q08 and is expected to be complete by 4Q09. The facility is designed to meet FDA and worldwide regulatory standards, and will provide GLP toxicology, immunology, vaccine, and bioanalytical services, according t...